Conference Coverage
-
Conference Coverage
Cerliponase alfa continues to impress for CLN2 disease
BANGKOK – The therapy durably slowed decline in motor and language function seen after 3 years of treatment.
-
Conference Coverage
Certain diabetes drugs may thwart dementia
COPENHAGEN – Intriguing findings from a Danish national registry study.
-
Conference Coverage
Smoking impairs cognition and shrinks brain volume in MS
STOCKHOLM – New evidence suggests the damage may be partially reversible.
-
Conference Coverage
Many children who present to headache clinics have joint hypermobility
CHARLOTTE, N.C. – Joint hypermobility is associated with a high likelihood of severe headache disability among...
-
Conference Coverage
Adolescent lung inflammation may trigger later MS
STOCKHOLM – Swedish national health care registry studies show associations between pneumonia or infectious mononucleosis occurring in early...
-
Conference Coverage
Does AED prophylaxis delay seizure onset in children with brain tumors?
CHARLOTTE, N.C. – A small study indicates that AED prophylaxis may be effective during the first 6 months after...
-
Conference Coverage
Celiac disease may underlie seizures
CHARLOTTE, N.C. – A gluten-free diet may reduce seizure burden in children with celiac disease and intractable seizures, a retrospective chart...
-
Conference Coverage
Baricitinib may benefit patients with Aicardi-Goutières syndrome
CHARLOTTE, N.C. – A compassionate use trial indicates that JAK inhibition may have a role in the treatment of genetic interferonopathies.
-
Conference Coverage
Blood test might rival PET scan for detecting brain amyloidosis
ST. LOUIS – A blood test that measures the plasma ratio of amyloid-beta 42 peptide to amyloid-beta peptide 40 can accurately screen cognitively...
-
Conference Coverage
Edasalonexent may slow progression of Duchenne muscular dystrophy
CHARLOTTE, N.C. – Functional measures and disease biomarkers stabilized when patients received the investigational NF-kB inhibitor.
-
Conference Coverage
Thromboembolic events more likely among CIDP patients with CVAD
AUSTIN, TEX. – Although the study matched patients by demographic factors, researchers did not adjust the analysis for risk factors or confounders...
-
Conference Coverage
Experts address barriers to genetic screening
WASHINGTON – Panel explores clinical implications of removing barriers to genetic testing for newborns and carriers.
-
Conference Coverage
Ataluren shows real-world benefit for nonsense mutation Duchenne muscular dystrophy
AUSTIN, TEX. – Side effects in children taking ataluren were primarily gastrointestinal upset, headache, and...
-
Conference Coverage
MS-related disability may be decreasing
STOCKHOLM – International data indicate that the prognosis of MS has improved, partly as a result of treatment.
Latest News
-
From the Journals
Soccer pros may face increased risk of death from neurodegenerative disease
Mortality associated with neurodegenerative disease was higher, and mortality associated with other causes lower, among former pro soccer players...
-
Latest News
Pediatric epilepsy surgery may improve cognition and behavior
CHARLOTTE, NC – Comorbidities may influence the likelihood of perceived improvement, whereas the type of surgery may not.
FDA/CDC
-
News from the FDA/CDC
FDA approves diroximel fumarate for relapsing MS
The oral drug, marketed as Vumerity, converts to the same active metabolite as dimethyl fumarate.
Literature Review
-
Literature Review
Insomnia symptoms increase likelihood of stroke and heart disease
A positive dose-response relationship exists between the number of insomnia symptoms and the risk of cardiocerebral vascular disease, according to...